Escherichia coli (UPEC) were investigated in 204 clinical isolates of E. coli recovered from urine cultures at counts ≥10 5 . The bacteria were classified into two groups according to the number of leukocytes in urine samples from which they were isolated: group I ≤8 leukocytes/ hpf, 104 strains; group II >8 leukocytes/hpf, 100 strains. Two multiplex PCR systems were used to detect genes encoding adhesin P (pap), adhesin S (sfa), afimbrial adhesin I (afa), siderophore aerobactin (aer), alpha-hemolysin (hly), cytotoxic necrotizing factor type 1 (cnf1), and traT associated with serum resistance. The PAI marker for the virulence island identified in strains CFT072 and CVD432, a marker of enteroaggregative E. coli, was also investigated using ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 10 (4): 4114-4125 (2011) Virulence genes in UPEC strains 4115
INTRODUCTION
Urinary tract infection (UTI) is one of the most common bacterial infections (Zhang and Foxman, 2003; Stamm, 2006) and is defined as a significant number of pathogenic organisms in the urinary system (Zhang and Foxman, 2003; Marrs et al., 2005) . Microscopy and culture of midstream urine is the gold standard diagnostic test for UTI. Quantitative bacteriuria of 10 5 colony forming units per mL (CFU/mL) is sufficient for a diagnosis of UTI (Chung et al., 2010) . Clinical manifestations of UTI are very variable in extent and severity, while cystitis generally resolves without sequelae, pyelonephritis can cause serious morbidity and can be fatal.
Escherichia coli is a commensal of the human intestine, although several strains have acquired specific virulence attributes, which confer the ability to adapt to new niches and cause a broad spectrum of disease (Kaper et al., 2004) . E. coli is by far the most common cause of UTI accounting for 80 -90% of all UTIs seen among ambulatory populations (Zhang and Foxman, 2003; Stamm, 2006; Talan et al., 2008) . These E. coli are named uropathogenic E. coli (UPEC) and have virulence properties that are associated with infection in the normal urinary tract including the expression of specific adhesins and toxins (Blanco et al., 1997a; Johnson and Stell, 2000; Kaper et al., 2004; Antão et al., 2009) .
Bacterial adherence to uroepithelial cells is an essential stage for the initiation and development of UTI. This process allows bacteria to resist the flushing action of the urine flow and bladder emptying, promoting bacterial persistence and activation of the host signaling pathways. UPEC strains are able to produce various types of adhesins necessary for the recognition and attaching to receptors along the urinary tract including type 1 fimbriae, coded by the fim gene cluster; P fimbriae, coded by pap (pyelonephritis-associated pili) genes (Roberts et al., 1994; Antão et al., 2009 ); S fimbriae, coded by sfa genes (Korhonen et al., 1984; Antão et al., 2009) ; and Afa adhesins, coded by afa genes, for afimbrial adhesins (Blanco et al., 1997a; Johnson and Stell 2000; Kaper et al., 2004) . It was shown that afa, pap and sfa are predictors of cystitis and/or pyelonephritis (Johnson et al., 2005) .
Production of toxins such as hemolysin and cytotoxic necrotizing factor 1 (CNF1) causes tissue damage facilitating bacterial dissemination, releasing of host nutrients, and may also modulate host signaling pathways affecting several processes, including inflammatory responses, host cell survival, and cytoskeletal dynamics (Wiles et al., 2008b) . It was shown that hemolysin provokes sloughing of the uroepithelium and bladder hemorrhage while CNF1 induces bladder inflammation and submucosal edema in mice (Smith et al., 2008) .
Other characteristics are also important for the UPEC ability to cause UTI. Among them, the expression of iron acquisition systems that utilize siderophores to scavenge iron from the environment and subsequently concentrate it in the bacterial cytosol is fundamental for the ability to colonize and persist in host iron-poor niches such as the urinary tract since limiting iron availability is an important host defense against invading bacterial pathogens (Russo et al., 1999; Wiles et al., 2008b) . Its importance is reflected by the presence of several iron acquisition systems in UPEC strains which are up regulated in vivo (Snyder et at., 2004) . Also, the serum resistance, the ability to avoid the bactericidal activity of serum, is a characteristic important for pathogenesis enabling bacteria to persist in body fluids and internal organs. The outer membrane protein TraT play a role in the defense of bacteria against serum killing (Binns et al., 1982; Mellata et al., 2003) .
Some recent studies have found markers of enteroaggregative E. coli (EAEC), a diarreagenic pathotype of E. coli, among UPEC strains suggesting that some EAEC are potentially uropathogens (Abe et al., 2008; Park et al., 2009) .
In this study E. coli strains isolated from urine with bacterial counts ≥10 5 CFU/mL were analyzed for presence of virulence factors and susceptibility to antimicrobials. The study was approved by the University's Research Ethics Committee.
MATERIAL AND METHODS

Bacterial strains
A total of 204 E. coli strains were isolated from urine samples of in-and out-patients in the Paraná Clínicas Laboratory in Curitiba, PR during the period of April to September 2010. UTI was confirmed by urine culture with bacterial counts ≥10 5 CFU/mL. Bacteria were identified using conventional microbiological methods and were divided into two groups according to the numbers of leukocytes present in the urine sample: discrete to moderate counts, ≤8/hpf (group I, 104 strains) or high, >8/hpf (group II, 100 strains). The bacteria were maintained in TSB/glycerol at -70°C.
Detection of virulence genes
The E. coli strains were grown overnight in MacConkey agar and isolated colonies were used for DNA extraction by the boiling method. Two distinct multiplex PCR assays were used to detect the presence of the virulence genes. Multiplex 1 included primers designed by Yamamoto et al. (1995) for the target genes pap (pilus associated with pyelonephritis), afa (afimbrial adhesin), sfa (S fimbriae), which code for adhesins; hly (hemolysin) and cnf1 (cytotoxic necrotizing factor 1) coding for toxins, and aer for siderophore aerobactin. Multiplex 2 contained primers PAI, a marker of the pathogenicity island of the pyelonephritogenic UPEC E. coli CFT073, and the serum resistance associated gene traT (Johnson and Stell, 2000) . The primers sequences are in Table 1 .
All the 204 UPEC strains were also tested for presence of CVD432, a plasmid sequence associated with enteroaggregative E. coli, using primers EAEC1 5ꞌ-CTGGCGAAAGACTGTATCAT-3ꞌ and EAEC2 5ꞌ-CAATGTATAGAAATCCGCTGTT-3ꞌ (Aranda et al., 2004) .
The Multiplex PCR assays were performed in a final volume of 25 µL, containing DNA (2 µL boiling lysate), 1.5 mM MgCl 2 , 0.2 mM dNTP, 1U Taq DNA Polymerase (Fermentas), 1X Taq DNA Polymerase Buffer, and 0.4 µM primers. For both multiplex systems the following program was used: 1 cycle of 94°C for 60 s; 30 cycles of 94°C for 60 s, 63°C for 30 s, 72°C for 90 s followed by a final cycle of 72°C for 300 s.
Strains EC 2 (traT pap aer hly), EC 3 (PAI sfa cnf1) and EC 71 (afa), were used as positive controls. The detection of PCR products was performed on 2% agarose gel electrophoresis in TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8.3), stained with ethidium bromide 0.5µg/mL and visualized under UV light.
DNA sequencing
The amplicons were sequenced using the DYEnamic ET Dye Terminator Cycle Sequencing kit (GE Healthcare Life Sciences) according to the manufacturer's instructions and an automatic DNA sequencer ABI Prism 377 (Applied Biosystems). Sequences were analyzed using the BioEdit, BLASTn and ClustalW softwares.
Antimicrobial susceptibility testing
The susceptibility test was carried out using the disk diffusion method according to the CLSI, 2010. The following antimicrobials were tested: amoxicillin-clavulanic acid, ampicillin, aztreonam, cefepime, cefoxitin, ceftriaxone, cephalothin, ciprofloxacin, gentamicin, nalidixic acid, trimethoprim/sulfamethoxazole and imipenem.
Hemolysis assay
The lytic capability of UPEC strains positive for hly gene was assessed by the method of Scheffer et al. (1988) with some modifications. Briefly, brain heart infusion (BHI) broth (10 mL) was inoculated with the E. coli strains and incubated at 37°C in an orbital shaker at 150 rpm. Aliquots of cultures were harvest at hourly intervals beginning after 4 h of incubation up to the 8th hour. The cell suspensions or culture supernatant (0.2 mL) were incubated for 2 h at 37°C with 0.2 mL suspension containing 10 8 /mL human erythrocytes in buffer (20 mM CaCl 2 , 10 mM Tris, and 140 mM NaCl, pH 7.4). The hemoglobin released in the supernatant was determined at 540 nm. The results are expressed as percent of lysis compared with that of erythrocytes lysed in distilled water and Triton X-100 0.1%.
Statistical methods
Comparisons for hemolytic assays were performed with one-way ANOVA and the Tukey post hoc test for average comparisons. Differences between non-continuous variables were tested by chi-square test or two-tailed Fisher exact test, as appropriate. The Pearson linear correlation test was used for correlation analysis. Statistical analyses were performed with Statistica for Windows, version 8.0 (StatSoft Inc., Tulsa, OK, USA). All results were considered as statistically significant at P < 0.05.
RESULTS
Virulence-associated characteristics
The marker CVD432 of plasmid pAA, associated with EAEC, was not found among the 204 UPEC strains analyzed. One hundred and eighty four strains (90%), presented at least one of the eight UPEC virulence associated genes tested (Table 2) , however in 20 strains (10%) none of these virulence genes were found. Fifty-seven strains (28%) had only one virulence gene; 45 strains (22%) two genes; combinations of three virulence genes were observed in 40 (20%) strains, and four to seven virulence genes in 42 (20%). None of the strains contained all the eight UPEC virulence associated genes tested.
The two groups of strains are significantly different considering the number of virulence genes (0, 1, 2, 3, or 4 -7) present in each UPEC (Table 2) . In group I, 39 strains contained only one virulence gene compared with 18 in group II (P = 0.003). In contrast, group II contained 29 strains with 4 or more virulence genes compared with only 13 in group I (P = 0.005). These results suggest that group I contains strains less virulent than those included in group II.
The prevalence of the UPEC virulence genes was traT (76%), aer (41%), PAI (32%), sfa (26%), pap (25%), cnf1 (18%), afa (6%) and hly (5%). However, except for hly, found only in strains of group II, no significant difference was found in the distribution of these genes between the two groups of strains. The virulence associated genes were distributed in 50 distinct patterns; of these 20 were common to strains belonging to both groups of UPEC. Seven patterns were observed only in strains of group I, and 23 only among strains belonging to group II, suggesting that the last group present greater variability (Table 2 ). Significant correlations were observed between the presence of some of the virulence genes and leukocytes counts (Figure 1 ).
The number of leukocytes was positively correlated with the marker for pathogenicity island PAI (p = 0.022), pap (P = 0.002), aer (P = 0.005) and hly (P < 0.001), indicating that the greater the leukocyte number the more frequent these virulence genes are found. Also a positive correlation of 0.702 (P < 0.001) was observed between cnf1 (found in 36 strains) and sfa (present in 53 strains) which were found together in 32 strains.
Genotype
Group The strains positive for hly were tested for the ability to cause lysis of human erythrocytes. Eight of the ten strains presented hemolytic activity (Table 3 ). The hemolytic activity of bacterial cultures was determined at different times during cell growth. E. coli strains induced hemolysis mainly after 3-4 h of bacterial growth. Then, the hemolysis induction rapidly decreased, as previously described (Scheffer et al, 1988; Johnson, 1991) . Two strains failed to produce significant hemolysis, however, since HlyA is a pore-forming toxin, at low concentration its binding not always lead to lysis (Boehm et al, 1990; Ostolaza and Goni,1995) . 64,2 ± 13,24*** UPEC 134
16,97 ± 2,4** UPEC 145 41,6 ± 2,99*** UPEC 162 41,6 ± 2,24*** Table 3 . Lytic capability of UPEC strains. **P < 0.01 and ***P < 0.001, compared with negative control.
Antimicrobial susceptibility test
One hundred and twenty strains (59%) showed resistance to one or more antimicrobials (Table 4) . Resistance was observed for all the antimicrobials tested: ampicillin (51%), trimethoprim ⁄ sulfamethoxazole (44%), nalidixic acid (21%), gentamicin (16%), ciprofloxacin (13%), cephalothin (4%), cefoxitin (1%), amoxicillin-clavulanic acid (1%), ceftriaxone, (1%), aztreonam, cefepime and imipenem (0.5% each). Resistance to ampicillin and sulfametoxazol/ trimetoprim (30%), ampicillin (13%), and ampicillin, ciprofloxacin, nalidixic acid and sulfametoxazol/trimetoprim (9%) were the most common (Table 4) . Fifty-one (42%) of these strains were multi-resistant, and a possible ESBL-producing strain was found.
Antimicrobial Strains (%)
Ampicillin, Trimethoprim/sulfamethoxazole 36 (30) Ampicillin 16 (13) Ampicillin, Nalidixic acid, Trimethoprim/sulfamethoxazole 11 (9) Ampicillin, Ciprofloxacin, Gentamicin, Nalidixic acid, Trimethoprim/sulfamethoxazole 6 (5) Gentamicin 6 (5) Trimethoprim/sulfamethoxazole 6 (5) Ampicillin, Gentamicin, Trimethoprim/sulfamethoxazole 6 (5) Ampicillin, Ciprofloxacin, Nalidixic acid, Trimethoprim/sulfamethoxazole 5 (4) Ampicillin, Cephalothin, Trimethoprim/sulfamethoxazole 5 (4) Ampicillin, Gentamicin, Nalidixic acid, Trimethoprim/sulfamethoxazole 4 (3) Cephalothin 2 (2) Ampicillin, Ciprofloxacin, Nalidixic acid 2 (2) Ampicillin, Cephalothin, Ciprofloxacin, Nalidixic acid, Trimethoprim ⁄ sulfamethoxazole 2 (2) Nalidixic acid 1 (1) Ampicillin, Ciprofloxacin 1 (1) Ampicillin, Nalidixic acid 1 (1) Gentamicin, Trimethoprim/sulfamethoxazole 1 (1) Ampicillin, Gentamicin, Nalidixic acid 1 (1) Ampicillin, Gentamicin, Nalidixic acid, Trimethoprim/sulfamethoxazole 1 (1) Ampicillin, Cephalothin, Gentamicin, Nalidixic acid, Trimethoprim/sulfamethoxazole 1 (1) Ampicillin, Ceftriaxone, Ciprofloxacin, Gentamicin, Nalidixic acid 1 (1) Ampicillin, Amoxicillin-clavulanic acid, Cefoxitin, Gentamicin, Nalidixic acid 1 (1) Ampicillin, Cefoxitin, Ciprofloxacin, Nalidixic acid, Trimethoprim/sulfamethoxazole 1 (1) Ampicillin, Amoxicillin-clavulanic acid, Ciprofloxacin, Gentamicin, Nalidixic acid, 1 (1) Trimethoprim/sulfamethoxazole Ampicillin, Ciprofloxacin, Gentamicin, Imipenem, Nalidixic acid, Trimethoprim/sulfamethoxazole 1 (1) Ampicillin, Aztreonam, Cefepime, Ceftriaxone, Cephalotin, Ciprofloxacin, Gentamicin, Nalidixic acid, 1 (1) Trimethoprim/sulfamethoxazole 
DISCUSSION
Recent studies have shown that some UPEC strains share some characteristics of EAEC (Abe et al., 2008; Park et al., 2009 ), a pathotype of diarrheagenic E. coli defined by characteristic aggregative adherence pattern to HEp-2 cells. Although no single virulence factor has been irrefutably associated with EAEC virulence, several of them are regulated by a single transcriptional factor called AggR coded by the aggR gene (Kaper et al., 2004) . The pattern of aggregative adherence was observed in 4% of UPEC strains, while the aggR gene was found in 3.1% (Abe et al., 2008) or 41% (Park et al., 2009 ) of isolates. Also the aatA gene, which code for the dispersin transporter protein complex, formerly known as EAEC or CVD432 gene, was detected in 3.6% of UPEC strains (Abe et al., 2008) . These results are in contrast with those found in the present work where no positive results for CVD 432 were found among the 204 UPEC strains tested. These discrepancies might be explained by the loss or absence of the plasmid that contains the EAEC sequences in the UPEC strains analyzed in this study, and also to heterogeneity in gene composition of the plasmid pAA associated with EAEC.
In 10% of strains analyzed in this work none of the eight UPEC associated virulence genes tested were found. Lack of virulence markers was also observed in other studies i.e. 41 and 51% of UPEC strains when tested respectively for presence of hly, cnf1, pap, sfa and afa (Blanco et al., 1997b) or pap, sfa and afa (Santo et al., 2006) . These findings reflect the heterogeneity in the distribution of virulence genes among UPEC strains and the complex and multifactorial characteristic of UPEC virulence (Johnson and Stell, 2000; Snyder et al., 2004) .
Several distinct patterns were found among the UPEC strains regarding the number of virulence genes and their distribution among the strains (Table 2) , a result also found in other studies (Blanco et al., 1997b; Johnson and Stell, 2000; Marrs et al., 2002) . High heterogeneity of the composition of virulence associated genes was found, and except for strains carrying only traT (51 strains, 25%), or traT aer (21 strains, 10%), most strains have a unique virulence gene pattern (Table 2 ). Similar finding was also observed by Marrs et al. (2002) , who found that only 5 to 10% of UPEC strains shared virulence gene patterns.
A significant difference was found among strains belonging to group I or II. A higher degree of virulence was found for UPEC of group II, associated with intense leukocyturia. This group contained a higher number of strains carrying multiple virulence genes (P = 0.005). Strains with only one virulence gene (P = 0.003), predominate in group I (milder leukocyturia). However, no statistically significant difference was found in the distribution of virulence genes between the two groups, except for hly (P = 0.033), which was found only in strains of group II. Eighty percent of the strains positive for hly induced significant lysis of human erythrocytes. α-hemolysin (HlyA), is associated with higher clinical severity in UTI patients (Johnson, 1991; Marrs et al, 2005) . Even sublytic concentrations of HlyA can produce inactivation of the serine/ threonine kinase Akt, which plays a central role in host cell cycle progression, metabolism, vesicular trafficking, survival, and inflammatory signaling pathways (Wiles et al., 2008a) .
The traT gene, associated with serum resistance, was the most prevalent, present in 77% of strains. Johnson and Stell (2000) found traT frequencies ranging from 59 to 83% according to the carboxylesterase B type and presence of PAI, whose frequency ranged from 26 to 96%. In the present work the PAI frequency was 33%, and no correlation was found between PAI and traT gene, which may be associated to differences in the distribution of traT bearing plasmids and variability of pathogenicity islands described in UPEC strains (Binns et al., 1892; Lloyd et al., 2007) .
The adhesins genes sfa and pap presented frequencies of 26 and 25%, respectively. Frequencies of sfa and pap varying from 0 to 64% and from 0 to 54%, respectively, have been reported in strains isolated from distinct groups of patients and belonging to different phylogenetic groups of UPEC (Blanco et al., 1997a; Santo et al., 2006; Takahashi et al., 2006 Takahashi et al., , 2009 . A significant positive correlation was found for simultaneous presence of sfa and pap (P < 0.001), which were found together in 11% of the strains. Since the binding to the host cells is a key factor for development of infection, the expression of different types of adhesins, with affinity to distinct specific receptors, confers advantages to pathogens (Antão et al., 2009) .
The afa gene presented the lowest frequency among the adhesins, being found in 6% of the strains. Frequencies of afa ranging from 2 to 11% have been reported (Blanco et al., 1997a; Santo et al., 2006; Takahashi et al., 2006; Abe et al., 2008) indicating a lower prevalence of this gene among UPEC.
Among the toxin genes, cnf1 was the most prevalent, present in 18% of strains, while hly was detected in only 5% of the strains, all belonging to group 2. Prevalence of these genes vary according to the phylogenetic group, clinical conditions of host and geographical localization. Frequencies ranging from 0 to 32% were found for cnf1; and from 0 to 44% for hly (Blanco et al., 1997b; Johnson and Stell, 2000; Takahashi et al., 2006 Takahashi et al., , 2009 Abe et al., 2008) .
Prevalence of aer was 41%, which is similar to those found in other studies, although a large variation in gene frequencies has also been been observed (Abe et al., 2008; Takahashi et al., 2006 Takahashi et al., , 2009 .
Several pathogenicity islands, with distinct genetic compositions, have been described in UPEC strains. The combination of the virulence genes pap aer hly (Table 2) , found in 9 strains, suggest the presence of the pathogenicity island I described in strain CFT073 (Guyer et al., 1998; Lloyd et al., 2007) . The best studied UPEC strains such as CFT073, J96, 536 and UTI89 have one or more pathogenicity island. Associations of the genes pap, hly and cnf1 and also sfa are present in some of them (Guyer et al., 1998; Oelschlaeger et al., 2002; Lloyd et al., 2007; Wiles et al., 2008b) . Associations of two or more of these genes were observed in some of the strains analyzed in this study, which is suggestive of the presence of pathogenicity island in these strains. For example, the strong positive correlation (P < 0.001; Figure 1) found between cnf1 and sfa may be a result of physical linkage between them, thus suggesting the presence of a pathogenicity island UTIs are common infections and increased antimicrobial resistance hinder their treatment. The most commonly used antibacterial drugs in the treatment of UTI are trimethoprimsulfamethoxazole, cephalosporins, semi-synthetic penicillins with or without beta-lactamase inhibitors and quinolones (Arslan et al., 2005; Chung et al., 2010) . A high frequency (59%) of UPEC strains resistant to one or more antimicrobials was found in the present work (Table 4) . The most frequent antimicrobial resistance found was against ampicillin (51%), in agreement with other studies that found ampicillin resistance ranging from 30 to 58% (McIsaac et al., 2004; Arslan et al., 2005; Houdouin et al., 2006; Talan et al., 2008) . The second most frequent resistance observed in this work was to trimethoprim/sulfamethoxazole (44%), again a common finding, with frequencies varying from 10.9 to 36% world-wide (McIsaac et al., 2004; Arslan et al., 2005; Houdouin et al., 2006; Talan et al., 2008) . Resistance to ciprofloxacin, also frequently used in the treatment of UTI, was found in 13% of strains; other studies found frequencies of 3% (Talan et al., 2008) , 9% (Houdouin et al., 2006) and 17% (Arslan et al., 2005) . These results show that resistance to the most frequently used antimicrobials agents are found in a high percentage of UPEC isolates, a cause for concern since this reduces the firstline alternatives for therapy.
A relationship between UPEC reduced virulence and antimicrobial resistance to quinolone and fluoroquinolone was observed in several studies. Nalidixic acid resistance was associated with a lower prevalence of sfa, pathogenicity island II J96 -like domains, strains of the phylogenetics subgroup B2/I, and group A (Houdouin et al., 2006) . Piatti et al. (2008) , found a higher prevalence of fluoroquinolone susceptible strains in the phylogenetic group B2. Also hly and cnf1 were found to be associated with susceptibility to fluoquinolone and with group B2. Moreover, within group B2, fluoroquinolone resistant strains showed lower prevalences of pap, hly and cnf1 than their susceptible counterparts. Similar results were also found by Takahashi et al. (2009) . In our work no statistical significant difference was found between quinolone and fluoroquinolone resistant strains and prevalence of virulence genes, indicating that the relationship may be influenced by the genetic background.
In summary, a high variability was found among UPEC strains regarding the distribution of virulence genes and more virulent strains were isolated from urine samples with stronger inflammatory response. A high level of resistance was found due to antimicrobials frequently used for UTI treatment.
